🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 4 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/05/2000 | 0,2767 USD |
| 01/03/2000 | 0,2767 USD |
| 01/12/1999 | 0,2767 USD |
| 01/09/1999 | 0,2767 USD |
| 02/06/1999 | 0,2576 USD |
| 03/03/1999 | 0,2576 USD |
| 02/12/1998 | 0,2576 USD |
| 02/09/1998 | 0,2576 USD |
| 03/06/1998 | 0,2147 USD |
| 04/03/1998 | 0,2147 USD |
| 03/12/1997 | 0,2147 USD |
| 03/09/1997 | 0,2147 USD |
| 05/06/1997 | 0,2004 USD |
| 05/03/1997 | 0,2004 USD |
| 05/12/1996 | 0,1908 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 26/01/1993 | 19,68 | 19,74 | 18,85 | 18,85 | -4,24% | 4,55% | 12.660.050 |
| 25/01/1993 | 19,98 | 19,98 | 19,62 | 19,68 | -2,66% | 1,79% | 4.892.064 |
| 22/01/1993 | 20,16 | 20,34 | 19,98 | 20,22 | +0,89% | 1,78% | 4.403.696 |
| 21/01/1993 | 19,86 | 20,04 | 19,74 | 20,04 | +1,82% | 1,50% | 5.204.787 |
| 20/01/1993 | 19,56 | 19,98 | 19,44 | 19,68 | +1,23% | 2,74% | 6.248.805 |
| 19/01/1993 | 19,80 | 19,80 | 19,38 | 19,44 | -1,51% | 2,11% | 7.253.208 |
| 18/01/1993 | 19,98 | 20,16 | 19,74 | 19,74 | -0,90% | 2,09% | 4.277.307 |
| 15/01/1993 | 20,10 | 20,46 | 19,86 | 19,92 | -0,60% | 2,97% | 8.515.838 |
| 14/01/1993 | 20,63 | 20,69 | 19,68 | 20,04 | -3,17% | 4,91% | 9.825.210 |
| 13/01/1993 | 20,52 | 20,75 | 20,28 | 20,69 | +1,46% | 2,33% | 3.634.464 |
| 12/01/1993 | 20,63 | 20,69 | 20,10 | 20,40 | -1,16% | 2,89% | 4.368.693 |
| 11/01/1993 | 20,22 | 20,93 | 20,10 | 20,63 | +1,76% | 4,13% | 5.095.166 |
| 08/01/1993 | 19,74 | 20,34 | 19,62 | 20,28 | +2,41% | 3,63% | 6.591.501 |
| 07/01/1993 | 20,04 | 20,16 | 19,68 | 19,80 | -1,19% | 2,38% | 7.316.717 |
| 06/01/1993 | 20,52 | 20,57 | 19,86 | 20,04 | -2,61% | 3,49% | 8.943.632 |
| 05/01/1993 | 20,93 | 20,93 | 20,28 | 20,57 | -1,71% | 3,13% | 4.702.166 |
| 04/01/1993 | 20,93 | 21,05 | 20,69 | 20,93 | +1,15% | 1,71% | 5.648.720 |
| 31/12/1992 | 20,93 | 21,05 | 20,69 | 20,69 | -1,42% | 1,71% | 3.913.022 |
| 30/12/1992 | 21,11 | 21,17 | 20,75 | 20,99 | -0,28% | 1,98% | 3.457.352 |
| 29/12/1992 | 21,35 | 21,53 | 20,99 | 21,05 | -1,12% | 2,51% | 3.159.510 |
| 28/12/1992 | 21,35 | 21,47 | 21,11 | 21,29 | -0,28% | 1,68% | 2.772.170 |
| 24/12/1992 | 21,47 | 21,53 | 21,23 | 21,35 | -0,56% | 1,39% | 2.631.318 |
| 23/12/1992 | 21,83 | 21,95 | 21,41 | 21,47 | -3,74% | 2,46% | 6.048.637 |
| 22/12/1992 | 22,60 | 22,66 | 21,95 | 22,30 | -1,58% | 3,17% | 3.072.736 |
| 21/12/1992 | 22,36 | 22,72 | 22,30 | 22,66 | +1,33% | 1,87% | 3.306.859 |
| 18/12/1992 | 22,42 | 22,42 | 22,07 | 22,36 | +0,81% | 1,60% | 9.036.066 |
| 17/12/1992 | 22,24 | 22,36 | 22,01 | 22,19 | +0,00% | 1,61% | 2.989.734 |
| 16/12/1992 | 22,36 | 22,48 | 22,07 | 22,19 | -0,53% | 1,87% | 2.971.290 |
| 15/12/1992 | 22,54 | 22,60 | 22,19 | 22,30 | -1,32% | 1,85% | 2.891.222 |
| 14/12/1992 | 22,60 | 22,78 | 22,48 | 22,60 | -0,26% | 1,32% | 2.409.352 |